dat.hine1989 {metadat} | R Documentation |
Studies on Prophylactic Use of Lidocaine After a Heart Attack
Description
Results from 6 studies evaluating mortality from prophylactic use of lidocaine in acute myocardial infarction.
Usage
dat.hine1989
Format
The data frame contains the following columns:
study | numeric | study number |
source | character | source of data |
n1i | numeric | number of patients in lidocaine group |
n2i | numeric | number of patients in control group |
ai | numeric | number of deaths in lidocaine group |
ci | numeric | number of deaths in control group |
Details
Hine et al. (1989) conducted a meta-analysis of death rates in randomized controlled trials in which prophylactic lidocaine was administered to patients with confirmed or suspected acute myocardial infarction. The dataset describes the mortality at the end of the assigned treatment period for control and intravenous lidocaine treatment groups for six studies. The question of interest is whether there is a detrimental effect of lidocaine. Because the studies were conducted to compare rates of arrhythmias following a heart attack, the studies, taken individually, are too small to detect important differences in mortality rates.
The data in this dataset were obtained from Table I in Normand (1999, p. 322).
Concepts
medicine, cardiology, risk differences
Author(s)
Wolfgang Viechtbauer, wvb@metafor-project.org, https://www.metafor-project.org
Source
Normand, S. T. (1999). Meta-analysis: Formulating, evaluating, combining, and reporting. Statistics in Medicine, 18(3), 321–359. https://doi.org/10.1002/(sici)1097-0258(19990215)18:3<321::aid-sim28>3.0.co;2-p
References
Hine, L. K., Laird, N., Hewitt, P., & Chalmers, T. C. (1989). Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction. Archives of Internal Medicine, 149(12), 2694–2698. https://doi.org/10.1001/archinte.1989.00390120056011
Examples
### copy data into 'dat' and examine data
dat <- dat.hine1989
dat
## Not run:
### load metafor package
library(metafor)
### calculate risk differences and corresponding sampling variances
dat <- escalc(measure="RD", n1i=n1i, n2i=n2i, ai=ai, ci=ci, data=dat)
dat
### meta-analysis of risk differences using a random-effects model
res <- rma(yi, vi, data=dat)
res
## End(Not run)